We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+10.37%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$32.9B
AUM Growth
+$3.25B
Cap. Flow
+$735M
Cap. Flow %
2.23%
Top 10 Hldgs %
20.5%
Holding
3,797
New
302
Increased
1,702
Reduced
1,533
Closed
189

Top Buys

Rank Stock Value
1
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
+$67M
2
QQQM icon
Invesco NASDAQ 100 ETF
QQQM
+$63.9M
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$55.6M
4
JMTG
JPMorgan Mortgage-Backed Securities ETF
JMTG
+$35.5M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$34.1M

Top Sells

Rank Stock Value
1
GSY icon
Invesco Ultra Short Duration ETF
GSY
+$52.3M
2
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$45.8M
3
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$30.7M
4
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$27.8M
5
BND icon
Vanguard Total Bond Market
BND
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 11.86%
2 Financials 5.23%
3 Consumer Discretionary 3.7%
4 Communication Services 2.92%
5 Industrials 2.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GEVO icon
3576
Gevo
GEVO
$401M
$22K ﹤0.01%
16,352
-1
-0% -$1
CGC
3577
Canopy Growth
CGC
$426M
$21K ﹤0.01%
16,926
+1,505
+10% +$2K
WTI icon
3578
W&T Offshore
WTI
$546M
$21K ﹤0.01%
+12,715
New +$18.7K
LXRX icon
3579
Lexicon Pharmaceuticals
LXRX
$1.04B
$20K ﹤0.01%
21,500
-575
-3% -$373
CGEN icon
3580
Compugen
CGEN
$228M
$19K ﹤0.01%
11,250
-275
-2% -$408
GLMD icon
3581
Galmed Pharmaceuticals
GLMD
$4.39M
$19K ﹤0.01%
+10,132
New +$14.9K
MVIS icon
3582
Microvision
MVIS
$89.7M
$18K ﹤0.01%
1,030
-109
-10% -$1.89K
PLG
3583
Platinum Group Metals
PLG
$189M
$18K ﹤0.01%
11,627
-253
-2% -$339
SGMO
3584
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$17K ﹤0.01%
31,790
+6,000
+23% +$3.56K
HYLN icon
3585
Hyliion Holdings
HYLN
$734M
$16K ﹤0.01%
+12,121
New +$17.7K
LWLG icon
3586
Lightwave Logic
LWLG
$1.12B
$16K ﹤0.01%
12,961
– –
SOHO
3587
DELISTED
Sotherly Hotels
SOHO
$16K ﹤0.01%
16,508
-1,500
-8% -$1.19K
VERU icon
3588
Veru
VERU
$46M
$16K ﹤0.01%
2,785
-139,544
-98% -$783K
RJET
3589
Republic Airways Holdings
RJET
$964M
$15K ﹤0.01%
1,066
– –
CUE icon
3590
Cue Biopharma
CUE
$131M
$14K ﹤0.01%
667
– –
PRPL icon
3591
Purple Innovation
PRPL
$28.7M
$14K ﹤0.01%
793
-4
-0.5% -$74
TRIB
3592
Trinity Biotech
TRIB
$8.01M
$14K ﹤0.01%
743
– –
ASRT
3593
DELISTED
Assertio
ASRT
$12K ﹤0.01%
1,269
-67
-5% -$644
HTCR icon
3594
HeartCore Enterprises
HTCR
$3.55M
$12K ﹤0.01%
1,245
-6,614
-84% -$77.6K
SKYQ
3595
Sky Quarry Inc
SKYQ
$13.1M
$11K ﹤0.01%
2,250
-176
-7% -$1.06K
OPEN icon
3596
Opendoor
OPEN
$3.54B
$10K ﹤0.01%
19,121
-3,026
-14% -$2.19K
ONCY
3597
Oncolytics Biotech
ONCY
$95.5M
$9K ﹤0.01%
+11,271
New +$5.97K
AQMS icon
3598
Aqua Metals
AQMS
$10.1M
$8K ﹤0.01%
1,571
-276
-15% -$3.04K
CLSD
3599
DELISTED
Clearside Biomedical
CLSD
$8K ﹤0.01%
700
– –
RVSNW icon
3600
Rail Vision Ltd Warrant
RVSNW
$721K
$7K ﹤0.01%
103,122
+15,000
+17% +$1.42K
142 143
144
145 146

Similar funds

TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Cambridge Investment Research Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Cambridge Investment Research Advisors held 3,797 positions worth $32.9B, up 11% from $29.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q2 2025 filing shows 302 new, 1,702 increased, 1,533 reduced and 189 closed positions. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 707,098 shares worth $35.5M. The largest sale was Invesco Ultra Short Duration ETF, an estimated $52.3M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 707,098 shares worth $35.5M.
  • Cambridge Investment Research Advisors added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2025, an estimated $67M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2025 reduction was Invesco Ultra Short Duration ETF, cutting an estimated $52.3M.
  • Cambridge Investment Research Advisors fully exited MicroSectors FANG+ ETNs due Jan 8 2038 in Q2 2025, selling an estimated $8.22M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $32.9B portfolio in Q2 2025.
  • Cambridge Investment Research Advisors opened 302 new positions and closed 189 in Q2 2025.
  • Cambridge Investment Research Advisors's portfolio value rose 11% quarter-over-quarter to $32.9B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.